Cargando…
Biosimilar medicines: creating sustainable competition in an era of a new patent cliff in biological medicines
Autor principal: | Van Baelen, Maarten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4603324/ http://dx.doi.org/10.1186/2052-3211-8-S1-P28 |
Ejemplares similares
-
Off-Patent Biological and Biosimilar Medicines in Belgium: A Market Landscape Analysis
por: Vandenplas, Yannick, et al.
Publicado: (2021) -
Design of multi-target activity landscapes that capture hierarchical activity cliff distributions
por: Dimova, Dilyana, et al.
Publicado: (2012) -
Patents and Strategic Inventing: The Corporate Inventor's Guide to Creating Sustainable Competitive Advantage
por: Nissing, Nicholas
Publicado: (2012) -
Off-Patent Biologicals and Biosimilars Tendering in Europe—A Proposal towards More Sustainable Practices
por: Barbier, Liese, et al.
Publicado: (2021) -
Patent cliff and strategic switch: exploring strategic design possibilities in the pharmaceutical industry
por: Song, Chie Hoon, et al.
Publicado: (2016)